UBS Group’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,464
Closed -$14.5K 10965
2022
Q4
$14.5K Buy
1,464
+124
+9% +$1.22K ﹤0.01% 8067
2022
Q3
$13K Hold
1,340
﹤0.01% 8100
2022
Q2
$13K Sell
1,340
-741
-36% -$7.18K ﹤0.01% 7586
2022
Q1
$20K Sell
2,081
-852
-29% -$8.21K ﹤0.01% 7477
2021
Q4
$28K Buy
+2,933
New +$28.4K ﹤0.01% 7470

Other funds holding HWEL

UBS Group's HWEL Position: Q1 2023 in Review

UBS Group sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q1 2023, closing a stake of 1,464 shares — an estimated $14.5K sold.

UBS Group first reported a position in HWEL in Q4 2021 and held it in 5 quarters. The position peaked at $28K in Q4 2021. 45 funds tracked by Wall St. Rank hold HWEL as of Q1 2023.

  • UBS Group reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,464 Healthwell Acquisition Corp. I Class A Common Stock shares in Q1 2023, an estimated $14.5K.
  • UBS Group first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 5 quarters.
  • UBS Group's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $28K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.